During the 1960s, the drug industry was the subject of two congressional investigations into its business practices and pricing policies, and in 1962, passage of the Drug Amendments mandated greater Food and Drug Administration authority over pharmaceutical development. In this article, I examine the industry's efforts to circumvent these political challenges by drawing on its longstanding relationship with academic physicians and the American Medical Association. Using the medical profession's shared concern about expanding government oversight over therapeutic practice, the industry called on academic physicians to join forces with it and establish an expert advisory body to guide government officials on pharmaceutical policy. Drawing on research in the archives of the University of Pennsylvania and the National Academy of Sciences and a careful reading of the trade and biomedical literature and congressional documents, I argue that by positioning themselves as pharmaceutical experts, the members of this industry--academic alliance gave industry a seat at the policy table and enabled it to challenge the efforts of pharmaceutical reformers to further increase the government's role in drug development. Keywords: pharmaceuticals, drug industry, industry--academic relations, drug regulation, Food and Drug Administration, health care reform
...More
Article
Daemmrich, Arthur;
(2007)
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation.
(/isis/citation/CBB000932013/)
Book
Daemmrich, Arthur;
Radin, Joanna;
(2007)
Perspectives on Risk and Regulation: The FDA at 100
(/isis/citation/CBB000930536/)
Book
Mikkael A. Sekeres;
(2022)
Drugs and the FDA: Safety, Efficacy, and the Public's Trust
(/isis/citation/CBB614307145/)
Article
Daemmrich, Arthur;
(2003)
Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate
(/isis/citation/CBB000502224/)
Article
Stevens, Rosemary A.;
(2008)
History and Health Policy in the United States: The Making of a Health Care Industry, 1948--2008
(/isis/citation/CBB000930675/)
Article
Abraham, John;
Davis, Courtney;
(2006)
Testing Times: The Emergence of the Practolol Disaster and Its Challenge to British Drug Regulation in the Modern Period
(/isis/citation/CBB000770617/)
Article
Sihn, Kyu-hwan;
(2013)
The Institutionalization of Pharmaceutical Administration after the Korean Liberation: Focusing on Regulating the Pharmaceutical Affairs Law (Yaksabeop) in 1953
(/isis/citation/CBB001214039/)
Chapter
Daemmrich, A.;
Greene, J.;
(2010)
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
(/isis/citation/CBB001221031/)
Article
Daemmrich, A.;
(2007)
Pharmaceutical Regulation in the United States and Europe
(/isis/citation/CBB001221028/)
Article
Appel, Jacob M.;
(2008)
“Physicians Are Not Bootleggers”: The Short, Peculiar Life of the Medicinal Alcohol Movement
(/isis/citation/CBB000930706/)
Article
Jessica Epstein;
(2018)
Drugs that Shaped the FDA: From Elixir Sulfanilamide to Thalidome
(/isis/citation/CBB942814659/)
Book
Shorter, Edward;
(2009)
Before Prozac: The Troubled History of Mood Disorders in Psychiatry
(/isis/citation/CBB000952059/)
Book
Hilts, Peter J.;
(2003)
Protecting America's Health: The FDA, Business, and One Hundred Years of Regulation
(/isis/citation/CBB000502240/)
Book
Miriam J. Laugesen;
(2016)
Fixing Medical Prices: How Physicians Are Paid
(/isis/citation/CBB605902836/)
Book
Gaudillière, Jean-Paul;
Hess, Volker;
(2008)
Ways of Regulating: Therapeutic Agents between Plants, Shops and Consulting Rooms
(/isis/citation/CBB001221032/)
Thesis
Quon, Nicole Ciewhon;
(2007)
Decisions at Scientific Agencies: How Do the NIH and the FDA Balance ExpertOpinions, Changing Agendas, and Political Pressure?
(/isis/citation/CBB001561535/)
Chapter
Hess, Volker;
(2008)
Secrets, Bureaucracy and the Public Drug Regulation in Prussia of the Early 19th Century
(/isis/citation/CBB001221034/)
Article
Roth, Andrew L.;
Dunsby, Joshua;
Bero, Lisa A.;
(2003)
Framing Processes in Public Commentary on US Federal Tobacco Control Regulation
(/isis/citation/CBB000651023/)
Thesis
Schwartz, Jason Lee;
(2012)
External Factors: Advisory Committees, Regulation, and American Public Health, 1962--1999
(/isis/citation/CBB001567388/)
Chapter
Simon, Jonathan;
(2008)
French Serum Regulation in 1895: The Necessary Minimum or the Maximum Possible?
(/isis/citation/CBB001221038/)
Be the first to comment!